Bone lineage proteins in the entheses of the midfoot in patients with spondyloarthritis

Journal of Rheumatology

Volumn 42, Issue 4, 2015, Pages 630-637

  Pacheco Tena, César ^a   Pérez Tamayo, Ruy ^b   Pineda, Carlos ^c   González Chávez, Susana A ^f   Quiñonez Flores, Celia ^a   Vitelly, Antonio Ugalde ^d   Inman, Robert D ^e   Aubin, Jane E ^b   Vázquez Mellado, Janitzia ^d   Burgos Vargas, Rubén ^b  

^a UNIVERSIDAD AUTÓNOMA DE CHIHUAHUA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

^e TORONTO WESTERN HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ankylosing spondylitis; Ankylosing tarsitis; Enthesitis related arthritis; Osteocalcin; Osteopontin

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL PRODUCT; BONE SIALOPROTEIN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE RELATED PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BONE DEVELOPMENT; BONE TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENCHONDRAL OSSIFICATION; ENTHESITIS; FEMALE; FIBROBLAST; FOOT DISEASE; FOOT PAIN; FOOT SWELLING; FOOT TENDERNESS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTRAMEMBRANOUS OSSIFICATION; MALE; MESENCHYME CELL; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; SPONDYLARTHRITIS; SYNOVIUM; TARSITIS; TENDON SHEATH; ANKYLOSIS; BONE; FOOT; METABOLISM; PATHOLOGY; YOUNG ADULT;

ADULT; ALKALINE PHOSPHATASE; ANKYLOSIS; BIOMARKERS; BONE AND BONES; CROSS-SECTIONAL STUDIES; FEMALE; FOOT; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; MALE; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE-RELATED PROTEIN; SPONDYLARTHRITIS; SYNOVIAL MEMBRANE; YOUNG ADULT;

EID: 84940543089     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140218     Document Type: Article

References (38)

1. Moll JM, Haslock I, Wright V. Seronegative spondarthritides. In: Scott JT, Copeman WSC, eds. Copeman's textbook of the rheumatic diseases. 5th ed. Edinburgh: Churchill Livingstone; 1978:578-91.
2. Casasola-Vargas JC, Castro Villegas MC, Morote G, Huerta Sil G, Muñoz Gomariz E, et al. A cross-sectional comparative study of Mexican and Spanish patients with spondyloarthropathies. Ann Rheum Dis 2004;63 Suppl 1:1111.
3. Burgos-Vargas R, Naranjo A, Castillo J, Katona G. Ankylosing spondylitis in the Mexican mestizo: patterns of disease according to age at onset. J Rheumatol 1989;16:186-91.
4. Burgos-Vargas R, Granados Arriola J. Ankylosing spondylitis and related diseases in the Mexican mestizo. In: Khan MA, ed. Seronegative spondyloarthropathies. Spine: state of the art reviews. Philadelphia: Hanley & Belfus; 1990:4;665-78.
5. Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006;8:R143.
6. Bollow M, Fischer T, Reisshauer H, Backhaus M, Sieper J, Hamm B, et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis-cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 2000;59:135-40.
7. François RJ, Neure L, Sieper J, Braun J. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 2006;65:713-20.
8. Appel H, Maier R, Bleil J, Hempfing A, Loddenkemper C, Schlichting U, et al. In situ analysis of interleukin-23-and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis. Arthritis Rheum 2013;65:1522-9.
9. Appel H, Maier R, Wu P, Scheer R, Hempfing A, Kayser R, et al. Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther 2011;13:R95.
10. Benjamin M, Toumi H, Suzuki D, Hayashi K, McGonagle D. Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis 2009;68:1003-10.
11. Appel H, Maier R, Loddenkemper C, Kayser R, Meier O, Hempfing A, et al. Immunohistochemical analysis of osteoblasts in zygapophyseal joints of patients with ankylosing spondylitis reveal repair mechanisms similar to osteoarthritis. J Rheumatol 2010;37:823-8.
12. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol 1998;76:899-910.
13. Liu F, Malaval L, Aubin JE. The mature osteoblast phenotype is characterized by extensive plasticity. Exp Cell Res 1997; 232:97-105.
14. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
15. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
16. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
17. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
18. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996;35:66-71.
19. Pacheco-Tena C, Londoño JD, Cazarín-Barrientos J, Martínez A, Vázquez-Mellado J, Moctezuma JF, et al. Development of a radiographic index to assess the tarsal involvement in patients with spondyloarthropathies. Ann Rheum Dis 2002;61:330-4.
20. Aubin JE, Turksen K. Monoclonal antibodies as tools for studying the osteoblast lineage. Microsc Res Tech 1996;33:128-40.
21. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38:499-505.
22. van Duivenvoorde LM, Dorris ML, Satumtira N, van Tok MN, Redlich K, Tak PP, et al. Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human ?2-microglobulin-transgenic rat model of spondylarthritis. Arthritis Rheum 2012;64:3210-9.
23. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993;7:1475-82.
24. Oliva F, Barisani D, Grasso A, Maffulli N. Gene expression analysis in calcific tendinopathy of the rotator cuff. Eur Cell Mater 2011;21:548-57.
25. Kim SY, Choi HY, Myung KB, Choi YW. The expression of molecular mediators in the idiopathic cutaneous calcification and ossification. J Cutan Pathol 2008;35:826-31.
26. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004;286:E686-96.
27. Mori N, Majima T, Iwasaki N, Kon S, Miyakawa K, Kimura C, et al. The role of osteopontin in tendon tissue remodeling after denervation-induced mechanical stress deprivation. Matrix Biol 2007;26:42-53.
28. Gundberg CM, Lian JB, Booth SL. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr 2012; 3:149-57.
29. Rui YF, Lui PPY, Rolf CG, Wong YM, Lee YW, Chan KM. Expression of chondro-osteogenic BMPs in clinical samples of patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc 2012;20:1409-17.
30. Pauly S, Klatte F, Strobel C, Schmidmaier G, Greiner S, Scheibel M, et al. BMP-2 and BMP-7 affect human rotator cuff tendon cells in vitro. J Shoulder Elb Surg 2012;21:464-73.
31. Manjila S, Miller E, Awadallah A, Murakami S, Cohen ML, Cohen AR. Ossified choroid plexus papilloma of the fourth ventricle: elucidation of the mechanism of osteogenesis in benign brain tumors. J Neurosurg Pediatr 2013;12:13-20.
32. Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008;10:R104.
33. Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Østergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009;60:93-102.
34. Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor ? inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013;65:2645-54.
35. Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, et al. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res 2012;64:1415-22.
36. Haynes KR, Pettit AR, Duan R, Tseng HW, Glant TT, Brown MA, et al. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors. Arthritis Res Ther 2012;14:R253.
37. Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005;115:1571-9.
38. Las Heras F, Pritzker KP, So A, Tsui HW, Chiu B, Inman RD, et al. Aberrant chondrocyte hypertrophy and activation of ?-catenin signaling precede joint ankylosis in ank/ank mice. J Rheumatol 2012;39:583-93.